Bio Green Med Preferred Shares Set for Nasdaq Delisting

The latest update is out from Bio Green Med Solution ( (BGMS) ).

Bio Green Med Solution, Inc. disclosed that on September 11, 2025 it was notified by Nasdaq that its 6% Convertible Exchangeable Preferred Stock, trading under the symbol BGMSP, had failed for 30 consecutive business days to meet the $1 million minimum market value of publicly held shares required for continued listing. The company was given until March 10, 2026 to regain compliance, but a March 12, 2026 notice from Nasdaq staff confirmed the preferred stock remained noncompliant and would be delisted from The Nasdaq Capital Market, with trading expected to move to the OTC Markets on or after April 2, 2026 while leaving the company’s BGMS common stock listing unaffected.

The company has stated it will not appeal Nasdaq’s determination, meaning trading in the preferred stock is scheduled to be suspended on March 23, 2026 and a delisting filing with the SEC will follow. This development shifts liquidity and price-discovery for holders of the preferred shares to the OTC Markets while preserving the Nasdaq listing of the common stock, creating a divergence in trading venues that could impact valuation, investor access, and the market profile of the company’s capital structure.

The most recent analyst rating on (BGMS) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Bio Green Med Solution stock, see the BGMS Stock Forecast page.

Spark’s Take on BGMS Stock

According to Spark, TipRanks’ AI Analyst, BGMS is a Neutral.

The score is primarily constrained by weak financial performance: very small revenue, deeply negative margins, and substantial ongoing cash burn despite an improved, low-debt balance sheet. Technicals also remain unfavorable with price below key moving averages and negative MACD. Valuation is mixed—an unusually high dividend yield provides some support, but the negative P/E underscores continued losses.

To see Spark’s full report on BGMS stock, click here.

More about Bio Green Med Solution

Bio Green Med Solution, Inc. is a listed company whose securities trade on The Nasdaq Capital Market, including its common stock under the symbol BGMS and its 6% Convertible Exchangeable Preferred Stock under the symbol BGMSP. The company has both common and preferred equity securities held by public investors, making its listing status and trading venues a key consideration for shareholders.

Average Trading Volume: 78,698

Technical Sentiment Signal: Strong Sell

Current Market Cap: $4.64M

See more data about BGMS stock on TipRanks’ Stock Analysis page.